SCHEMBL21892895

SCHEMBL21892895

CCCCBC(CC)(CC)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentane SCHEMBL8834784 0.58 TSHR (0.67) —
SCHEMBL969593 0.58 — —
Hexane SCHEMBL8853719 0.58 TSHR (0.67) —
Pentane SCHEMBL9108978 0.58 TSHR (0.58) —
Hexane SCHEMBL28709670 0.57 TSHR (0.64) —
Pentane SCHEMBL2022227 0.57 TSHR (0.70) —
SCHEMBL20991912 0.56 TSHR (0.42) —
Heptane SCHEMBL11520180 0.56 TSHR (0.61) —
Ammonia Solution, Strong SCHEMBL3821703 0.56 TSHR (0.43) —
Decane SCHEMBL10984014 0.56 TSHR (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200087270-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2020-03-19 — — US disclosed
Send feedback